Professor Richard Scolyer, an Australian pathologist, applied his melanoma immunotherapy research to treat his own aggressive brain cancer, glioblastoma. His innovative approach led to a remission period of nearly two years, offering hope for future treatments. Although his cancer has returned, his case has paved the way for upcoming clinical trials.⁠ ⁠ #braincancer #immunotherapy #medicalinnovation #glioblastoma #richardscolyer